| E |
New Cyclic Somatostatin Analogues Containing a Pyrazinone Ring: Importance of Tyr for Antiproliferative Activity. A.Miyazaki, Y.Tsuda, S.Fukushima, T.Yokoi, T.Vántus, G.Bökönyi, E.Szabó, A.Horváth, G.Kéri and Y.Okada; Bioorg.Med.Chem.Lett.,18,6199-6201(2009). |
| E |
Synthesis of Somatostatin Analogues Containing C-Terminal Adamantane and Their Antiproliferative Properties. A.Miyazaki, Y.Tsuda, S.Fukushima, T.Yokoi, T.Vántus, G.Bökönyi, E.Szabó, A.Horváth, G.Kéri and Y.Okada; J.Med.Chem.,51,5121-5124(2008). |
| E |
Potent Dmt-Tic Pharmacophoric ƒÂ- and ƒÊ-Opioid Receptor Antagonists. T.Li, Y.Fujita, K.Shiotani, A.Miyazaki, Y.Tsuda, A.Ambo, Y.Sasaki, Y.Jinsmaa, E.Marczak, S.D.Bryant, S.Salvadori, L.H.Lazarus and Y.Okada; J.Med.Chem.,48,8035-8044(2005). |
| E |
Studies on the Mechanism of 1,2-Dihydropyrazin-2-one Ring Formation from Dipeptidyl Chloromethyl Ketone and Its Chemical Properties: Immediate Deamination during Catalytic Hydrogenation. A.Miyazaki, Y.Fujisawa, K.Shiotani, Y.Fujita, T.Li, Y.Tsuda, T.Yokoi, S.D.Bryant, L.H.Lazarus and Y.Okada; Chem.Pharm.Bull.,53(9),1152-1158(2005). |
| E |
Design and synthesis of novel type somatostatin analogs with antiproliferative activities on A431 tumorcells. A.Miyazaki, T.Yokoi, Y.Tachibana, R.Enomoto, E.Lee, G.Bökönyi, G.Kéri, Y.Tsuda and Y.Okada; Tetrahedron Lett.,45,6323-6327(2004). |
|
|